Genetic association between NRG1 and schizophrenia, major depressive disorder, bipolar disorder in Han Chinese population

Schizophrenia, major depressive disorder, and bipolar disorder are three major psychiatric disorders affecting around 0.66%, 3.3%, and 1.5% of the Han Chinese population respectively. Several genetic linkage analyses and genome wide association studies identified NRG1 as a susceptibility gene of schizophrenia, which was validated by its role in neurodevelopment, glutamate, and other neurotransmitter receptor expression regulation. To further investigate whether NRG1 is a shared risk gene for major depressive disorder, bipolar disorder as well as schizophrenia, we performed an association study among 1,248 schizophrenia cases, 1,056 major depression cases, 1,344 bipolar disorder cases, and 1,248 controls. Totally 15 tag SNPs were genotyped and analyzed, and no population stratification was found in our sample set. Among the sites, rs4236710 (corrected Pgenotye = 0.015) and rs4512342 (Pallele = 0.03, Pgenotye = 0.045 after correction) were associated with schizophrenia, and rs2919375 (corrected Pgenotye = 0.004) was associated with major depressive disorder. The haplotype rs4512342‐rs6982890 showed association with schizophrenia (P = 0.03 for haplotype “TC” after correction), and haplotype rs4531002‐rs11989919 proved to be a shared risk factor for both major depressive disorder (“CC”: corrected P = 0.009) and bipolar disorder (“CT”: corrected P = 0.003). Our results confirmed that NRG1 was a shared common susceptibility gene for major mental disorders in Han Chinese population. © 2016 Wiley Periodicals, Inc.

[1]  P. Guest,et al.  Proteomic Enrichment Analysis of Psychotic and Affective Disorders Reveals Common Signatures in Presynaptic Glutamatergic Signaling and Energy Metabolism , 2015, The international journal of neuropsychopharmacology.

[2]  Xiao-hong Ma,et al.  Association of the 3' region of the neuregulin 1 gene with bipolar I disorder in the Chinese Han population. , 2014, Journal of affective disorders.

[3]  Jianxin Shi,et al.  Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs , 2013, Nature Genetics.

[4]  Li Su,et al.  Epidemiology of Major Depressive Disorder in Mainland China: A Systematic Review , 2013, PloS one.

[5]  M. Daly,et al.  Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis , 2013, The Lancet.

[6]  Martin Engel,et al.  Neuregulin-1 signalling and antipsychotic treatment , 2013, Psychopharmacology.

[7]  D. Rujescu,et al.  Fine mapping of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder , 2011, Molecular Psychiatry.

[8]  K. Merikangas,et al.  Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. , 2011, Archives of general psychiatry.

[9]  J. Lieberman,et al.  Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. , 2010, The American journal of psychiatry.

[10]  J. Lieberman,et al.  Signaling pathways in schizophrenia: emerging targets and therapeutic strategies. , 2010, Trends in pharmacological sciences.

[11]  Akira Sawa,et al.  Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1–ErbB4 and DISC1 , 2009, Trends in Neurosciences.

[12]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[13]  M C O'Donovan,et al.  The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia , 2009, Molecular Psychiatry.

[14]  Tyrone D. Cannon,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2009, The Lancet.

[15]  Henry A. Nasrallah,et al.  Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology , 2008, Schizophrenia Research.

[16]  M. Webster,et al.  Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients , 2008, Schizophrenia Research.

[17]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: dominant markers and null alleles , 2007, Molecular ecology notes.

[18]  M. Daly,et al.  Transferability of tag SNPs in genetic association studies in multiple populations , 2006, Nature Genetics.

[19]  Didier Cros,et al.  Neuregulin 1–erbB Signaling Is Necessary for Normal Myelination and Sensory Function , 2006, The Journal of Neuroscience.

[20]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[21]  Lin He,et al.  SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci , 2005, Cell Research.

[22]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[23]  D. Javitt,et al.  Glutamate as a therapeutic target in psychiatric disorders , 2004, Molecular Psychiatry.

[24]  S. Tsai,et al.  Case-control and family-based association studies between the neuregulin 1 (Arg38Gln) polymorphism and schizophrenia , 2004, Neuroscience Letters.

[25]  H. Stefánsson,et al.  Identification of a novel neuregulin 1 at-risk haplotype in Han schizophrenia Chinese patients, but no association with the Icelandic/Scottish risk haplotype , 2004, Molecular Psychiatry.

[26]  R Hashimoto,et al.  Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia , 2004, Molecular Psychiatry.

[27]  T. Suzuki,et al.  No association with the neuregulin 1 haplotype to Japanese schizophrenia , 2004, Molecular Psychiatry.

[28]  J. Smoller,et al.  Family, twin, and adoption studies of bipolar disorder , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[29]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[30]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[31]  G Kalsi,et al.  Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. , 2001, American journal of human genetics.

[32]  B. Gutiérrez,et al.  Increased morbid risk for schizophrenia in families of in-patients with bipolar illness , 2000, Schizophrenia Research.

[33]  G. Crane The psychotropic effects of cycloserine: A new use for an antibiotic , 1961 .

[34]  J. Stockman,et al.  Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study , 2010 .

[35]  Tao Li,et al.  A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn) , 2009, Cell Research.

[36]  Sarah Tosato,et al.  Association between the neuregulin 1 gene and schizophrenia: a systematic review. , 2005, Schizophrenia bulletin.

[37]  S. Purcell,et al.  Support for involvement of neuregulin 1 in schizophrenia pathophysiology , 2005, Molecular Psychiatry.

[38]  G. He,et al.  Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population , 2004, Molecular Psychiatry.

[39]  Hongyan Zhang,et al.  Association study of neuregulin 1 gene with schizophrenia , 2003, Molecular Psychiatry.

[40]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[41]  H. Stefánsson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.